Related Experiment Video
Updated: Mar 22, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Comparative pathophysiological modeling: the advantage of "two-hit" over "one-hit" in acute liver failure studies
Yishu Yan1, Jingping Huang1, Mingzhu Chen1
1School of Life Sciences and Health Engineering, Jiangnan University, No. 1800, Lihu Avenue, Wuxi, 214122, China.
Abstract:
Acute liver failure (ALF), a life-threatening condition marked by rapid hepatocyte death and systemic inflammation, poses significant clinical challenges due to its high mortality. The crosstalk between necrotic hepatocytes and infiltrating immune cells is hypothesized to drive disease progression. To investigate this interplay, we developed a sequential "two-hit" murine model using concanavalin A (Con A) challenges and compared its pathophysiological outcomes with the conventional single-dose "one-hit" approach. The results demonstrated that the "two-hit" model induced more severe hepatic coagulation dysfunction, extensive hepatocellular necrosis, destruction of liver lobular architecture, and inflammatory responses. Furthermore, serum levels of alanine transaminase (ALT) and aspartate transaminase (AST) were markedly elevated in the "two-hit" group. Inflammatory cytokines including interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) were also significantly elevated. Moreover, substantial recruitment of macrophages was observed in the "two-hit" model, indicating that these cells are key determinants in the interaction with dying hepatocytes for the progression of ALF. Complementary ex vivo experiments revealed that Raw264.7 cells subjected to a "two-hit" stimulation with Con A and hepatocyte debris produced a robust inflammatory response through the classical NF-κB signaling pathway.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...

